1 Study Coverage
1.1 Encephalitis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Encephalitis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Encephalitis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Encephalitis Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Encephalitis Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Encephalitis Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Encephalitis Vaccine Sales by Region
2.4.1 Global Encephalitis Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Encephalitis Vaccine by Region (2023-2028)
2.5 Global Encephalitis Vaccine Revenue by Region
2.5.1 Global Encephalitis Vaccine Revenue by Region (2017-2022)
2.5.2 Global Encephalitis Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Encephalitis Vaccine Sales by Manufacturers
3.1.1 Global Top Encephalitis Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Encephalitis Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Encephalitis Vaccine in 2021
3.2 Global Encephalitis Vaccine Revenue by Manufacturers
3.2.1 Global Encephalitis Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Encephalitis Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Encephalitis Vaccine Revenue in 2021
3.3 Global Encephalitis Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Encephalitis Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Encephalitis Vaccine Sales by Type
4.1.1 Global Encephalitis Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Encephalitis Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Encephalitis Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Encephalitis Vaccine Revenue by Type
4.2.1 Global Encephalitis Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Encephalitis Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Encephalitis Vaccine Price by Type
4.3.1 Global Encephalitis Vaccine Price by Type (2017-2022)
4.3.2 Global Encephalitis Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Encephalitis Vaccine Sales by Application
5.1.1 Global Encephalitis Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Encephalitis Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Encephalitis Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Encephalitis Vaccine Revenue by Application
5.2.1 Global Encephalitis Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Encephalitis Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Encephalitis Vaccine Price by Application
5.3.1 Global Encephalitis Vaccine Price by Application (2017-2022)
5.3.2 Global Encephalitis Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Encephalitis Vaccine Market Size by Type
6.1.1 North America Encephalitis Vaccine Sales by Type (2017-2028)
6.1.2 North America Encephalitis Vaccine Revenue by Type (2017-2028)
6.2 North America Encephalitis Vaccine Market Size by Application
6.2.1 North America Encephalitis Vaccine Sales by Application (2017-2028)
6.2.2 North America Encephalitis Vaccine Revenue by Application (2017-2028)
6.3 North America Encephalitis Vaccine Market Size by Country
6.3.1 North America Encephalitis Vaccine Sales by Country (2017-2028)
6.3.2 North America Encephalitis Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Encephalitis Vaccine Market Size by Type
7.1.1 Europe Encephalitis Vaccine Sales by Type (2017-2028)
7.1.2 Europe Encephalitis Vaccine Revenue by Type (2017-2028)
7.2 Europe Encephalitis Vaccine Market Size by Application
7.2.1 Europe Encephalitis Vaccine Sales by Application (2017-2028)
7.2.2 Europe Encephalitis Vaccine Revenue by Application (2017-2028)
7.3 Europe Encephalitis Vaccine Market Size by Country
7.3.1 Europe Encephalitis Vaccine Sales by Country (2017-2028)
7.3.2 Europe Encephalitis Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Encephalitis Vaccine Market Size by Type
8.1.1 Asia Pacific Encephalitis Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Encephalitis Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Encephalitis Vaccine Market Size by Application
8.2.1 Asia Pacific Encephalitis Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Encephalitis Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Encephalitis Vaccine Market Size by Region
8.3.1 Asia Pacific Encephalitis Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Encephalitis Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Encephalitis Vaccine Market Size by Type
9.1.1 Latin America Encephalitis Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Encephalitis Vaccine Revenue by Type (2017-2028)
9.2 Latin America Encephalitis Vaccine Market Size by Application
9.2.1 Latin America Encephalitis Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Encephalitis Vaccine Revenue by Application (2017-2028)
9.3 Latin America Encephalitis Vaccine Market Size by Country
9.3.1 Latin America Encephalitis Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Encephalitis Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Encephalitis Vaccine Market Size by Type
10.1.1 Middle East and Africa Encephalitis Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Encephalitis Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Encephalitis Vaccine Market Size by Application
10.2.1 Middle East and Africa Encephalitis Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Encephalitis Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Encephalitis Vaccine Market Size by Country
10.3.1 Middle East and Africa Encephalitis Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Encephalitis Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Valneva
11.1.1 Valneva Corporation Information
11.1.2 Valneva Overview
11.1.3 Valneva Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Valneva Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Valneva Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Corporation Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Pasteur Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Pasteur Recent Developments
11.3 Biken
11.3.1 Biken Corporation Information
11.3.2 Biken Overview
11.3.3 Biken Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biken Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biken Recent Developments
11.4 Wuhan Institute of Biological Products
11.4.1 Wuhan Institute of Biological Products Corporation Information
11.4.2 Wuhan Institute of Biological Products Overview
11.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Wuhan Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Wuhan Institute of Biological Products Recent Developments
11.5 Lanzhou Institute of Biological Products
11.5.1 Lanzhou Institute of Biological Products Corporation Information
11.5.2 Lanzhou Institute of Biological Products Overview
11.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lanzhou Institute of Biological Products Recent Developments
11.6 Chengdu Institute of Biological Products
11.6.1 Chengdu Institute of Biological Products Corporation Information
11.6.2 Chengdu Institute of Biological Products Overview
11.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Chengdu Institute of Biological Products Recent Developments
11.7 Tiantan Biological Products
11.7.1 Tiantan Biological Products Corporation Information
11.7.2 Tiantan Biological Products Overview
11.7.3 Tiantan Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Tiantan Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tiantan Biological Products Recent Developments
11.8 Liaoning Chengda
11.8.1 Liaoning Chengda Corporation Information
11.8.2 Liaoning Chengda Overview
11.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Liaoning Chengda Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Liaoning Chengda Recent Developments
11.9 Zhejiang Tianyuan Bio-Pharmaceutical
11.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
11.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Overview
11.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
11.10 Yisheng Bio
11.10.1 Yisheng Bio Corporation Information
11.10.2 Yisheng Bio Overview
11.10.3 Yisheng Bio Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Yisheng Bio Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yisheng Bio Recent Developments
11.11 Changchun Institute of Biological Products
11.11.1 Changchun Institute of Biological Products Corporation Information
11.11.2 Changchun Institute of Biological Products Overview
11.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Changchun Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Changchun Institute of Biological Products Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Encephalitis Vaccine Industry Chain Analysis
12.2 Encephalitis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Encephalitis Vaccine Production Mode & Process
12.4 Encephalitis Vaccine Sales and Marketing
12.4.1 Encephalitis Vaccine Sales Channels
12.4.2 Encephalitis Vaccine Distributors
12.5 Encephalitis Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Encephalitis Vaccine Industry Trends
13.2 Encephalitis Vaccine Market Drivers
13.3 Encephalitis Vaccine Market Challenges
13.4 Encephalitis Vaccine Market Restraints
14 Key Findings in The Global Encephalitis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Encephalitis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Encephalitis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Encephalitis Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Encephalitis Vaccine Sales by Region (2017-2022) & (M Doses)
Table 7. Global Encephalitis Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Encephalitis Vaccine Sales by Region (2023-2028) & (M Doses)
Table 9. Global Encephalitis Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Encephalitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Encephalitis Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Encephalitis Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Encephalitis Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Encephalitis Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Encephalitis Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Encephalitis Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Encephalitis Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Encephalitis Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Encephalitis Vaccine as of 2021)
Table 21. Encephalitis Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Encephalitis Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Encephalitis Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 26. Global Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 27. Global Encephalitis Vaccine Sales Share by Type (2017-2022)
Table 28. Global Encephalitis Vaccine Sales Share by Type (2023-2028)
Table 29. Global Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Encephalitis Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Encephalitis Vaccine Revenue Share by Type (2023-2028)
Table 33. Encephalitis Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Encephalitis Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 36. Global Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 37. Global Encephalitis Vaccine Sales Share by Application (2017-2022)
Table 38. Global Encephalitis Vaccine Sales Share by Application (2023-2028)
Table 39. Global Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Encephalitis Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Encephalitis Vaccine Revenue Share by Application (2023-2028)
Table 43. Encephalitis Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Encephalitis Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 46. North America Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 47. North America Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 50. North America Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 51. North America Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)
Table 54. North America Encephalitis Vaccine Sales by Country (2023-2028) & (M Doses)
Table 55. North America Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Encephalitis Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Encephalitis Vaccine Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Encephalitis Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Encephalitis Vaccine Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Encephalitis Vaccine Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Encephalitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Encephalitis Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Encephalitis Vaccine Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Encephalitis Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Encephalitis Vaccine Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Encephalitis Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Encephalitis Vaccine Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Encephalitis Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Encephalitis Vaccine Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Encephalitis Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Valneva Corporation Information
Table 106. Valneva Description and Major Businesses
Table 107. Valneva Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Valneva Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Valneva Recent Developments
Table 110. Sanofi Pasteur Corporation Information
Table 111. Sanofi Pasteur Description and Major Businesses
Table 112. Sanofi Pasteur Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Sanofi Pasteur Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofi Pasteur Recent Developments
Table 115. Biken Corporation Information
Table 116. Biken Description and Major Businesses
Table 117. Biken Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Biken Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Biken Recent Developments
Table 120. Wuhan Institute of Biological Products Corporation Information
Table 121. Wuhan Institute of Biological Products Description and Major Businesses
Table 122. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Wuhan Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Wuhan Institute of Biological Products Recent Developments
Table 125. Lanzhou Institute of Biological Products Corporation Information
Table 126. Lanzhou Institute of Biological Products Description and Major Businesses
Table 127. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Lanzhou Institute of Biological Products Recent Developments
Table 130. Chengdu Institute of Biological Products Corporation Information
Table 131. Chengdu Institute of Biological Products Description and Major Businesses
Table 132. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Chengdu Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Chengdu Institute of Biological Products Recent Developments
Table 135. Tiantan Biological Products Corporation Information
Table 136. Tiantan Biological Products Description and Major Businesses
Table 137. Tiantan Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Tiantan Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Tiantan Biological Products Recent Developments
Table 140. Liaoning Chengda Corporation Information
Table 141. Liaoning Chengda Description and Major Businesses
Table 142. Liaoning Chengda Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Liaoning Chengda Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Liaoning Chengda Recent Developments
Table 145. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 146. Zhejiang Tianyuan Bio-Pharmaceutical Description and Major Businesses
Table 147. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
Table 150. Yisheng Bio Corporation Information
Table 151. Yisheng Bio Description and Major Businesses
Table 152. Yisheng Bio Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Yisheng Bio Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Yisheng Bio Recent Developments
Table 155. Changchun Institute of Biological Products Corporation Information
Table 156. Changchun Institute of Biological Products Description and Major Businesses
Table 157. Changchun Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Changchun Institute of Biological Products Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Changchun Institute of Biological Products Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Encephalitis Vaccine Distributors List
Table 163. Encephalitis Vaccine Customers List
Table 164. Encephalitis Vaccine Market Trends
Table 165. Encephalitis Vaccine Market Drivers
Table 166. Encephalitis Vaccine Market Challenges
Table 167. Encephalitis Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Encephalitis Vaccine Product Picture
Figure 3. Global Encephalitis Vaccine Market Share by Type in 2021 & 2028
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Encephalitis Vaccine Market Share by Application in 2021 & 2028
Figure 6. Child
Figure 7. Adult
Figure 8. Encephalitis Vaccine Report Years Considered
Figure 9. Global Encephalitis Vaccine Sales 2017-2028 (M Doses)
Figure 10. Global Encephalitis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Encephalitis Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Encephalitis Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Encephalitis Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Encephalitis Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Encephalitis Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 16. North America Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Encephalitis Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 18. Europe Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Encephalitis Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 20. Asia-Pacific Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Encephalitis Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 22. Latin America Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Encephalitis Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 24. Middle East & Africa Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Encephalitis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Encephalitis Vaccine in the World: Market Share by Encephalitis Vaccine Revenue in 2021
Figure 27. Global Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 38. U.S. Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Encephalitis Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Encephalitis Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Latin America Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Latin America Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 72. Latin America Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 73. Mexico Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 82. Turkey Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Encephalitis Vaccine Value Chain
Figure 86. Encephalitis Vaccine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
